Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Bio Green Med Solution's Debt-to-Equity or its related term are showing as below:
During the past 13 years, the highest Debt-to-Equity Ratio of Bio Green Med Solution was 0.10. The lowest was -0.01. And the median was 0.01.
BGMS's Debt-to-Equity is not ranked *
in the Construction industry.
Industry Median: 0.41 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Bio Green Med Solution Debt-to-Equity Related Terms
Bio Green Med Solution Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Bio Green Med Solution's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGMS vs SILO, ALZN, ENVB: Debt-to-Equity Comparison
For the Building Products & Equipment subindustry, Bio Green Med Solution's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Green Med Solution Debt-to-Equity vs Construction Industry
For the Construction industry and Industrials sector, Bio Green Med Solution's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Bio Green Med Solution's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Green Med Solution (BGMS) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Bio Green Med Solution and its competitors. According to the industry distribution chart, Bio Green Med Solution ranks #999999 out of 1612 companies in the Construction industry.
Is Bio Green Med Solution's Debt-to-Equity too high?
Bio Green Med Solution's current Debt-to-Equity is 0.00. Based on the distribution chart, Bio Green Med Solution ranks #999999 out of 1612 companies in the Construction industry, which is in the bottom quartile relative to peers. Overall, Bio Green Med Solution has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio Green Med Solution's Debt-to-Equity compare to SILO and ALZN?
According to the Construction industry distribution chart, Bio Green Med Solution ranks #999999 out of 1612 companies for Debt-to-Equity. This places Bio Green Med Solution in the lower half of its industry. The industry median Debt-to-Equity is 0.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Construction company?
The median Debt-to-Equity among Construction companies is 0.41, based on 1,612 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Bio Green Med Solution and its competitors. For the Construction industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Green Med Solution's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Green Med Solution stock overvalued right now?
Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.56, compared to a current price of $0.97 — trading 62.1% below its estimated fair value. The current Debt-to-Equity is 0.00. Bio Green Med Solution's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio Green Med Solution (BGMS) Overvalued in 2026?
Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued.
The current stock price of $0.97 is trading 62.1% below its estimated GF Value™ of $2.56.
GuruFocus considers Bio Green Med Solution to be Possible Value Trap.
Key valuation signals for BGMS:
Debt-to-Equity: 0.00
GF Value™: $2.56 vs. price of $0.97 (62.1% below fair value)
No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
47GF Score
Get the complete analysis for BGMS
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGMS has been successfully added to your 
